AVRA Medical Robotics Announces Extension of Research Agreement with University of Central Florida

ORLANDO, Fla., May 16, 2019 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (the “Company” or “AVRA”) (OTCQB: AVMR), an emerging company that is creating the next generation of autonomous surgical robotics through the use of technologies such as artificial intelligence, machine learning and proprietary medical software architecture, announced today it has extended its research contract through April 2021 with the University of Central Florida (UCF), one of the largest universities in the U.S. Since 2016, AVRA and UCF have been collaborating to develop navigation and control technologies with applications in medical robotics. 

As part of this research agreement, UCF engineering students under the direction of Electrical Engineering Professor Zhihua Qu, continue to assist AVRA with its research and development of autonomous medical robotics. AVRA’s robotics lab is located in Central Florida’s Research Park, in close proximity to UCF’s main campus.

“We are pleased to formally extend our relationship with UCF,” said Barry Cohen, Chairman and Chief Executive Officer of AVRA. “This relationship has been nothing less than a ‘win-win’ for AVRA and UCF. Their students are an excellent resource for AVRA and have contributed tremendously to making improvements to our first-generation autonomous robotic arm by helping with the platform’s software, its controls, and navigation system. Being able to tap into a leading university for autonomous robotics has been an important relationship for AVRA and we look forward to continued collaboration with Dr. Qu and his students and UCF staff.”

Collaborations with industry are important to universities for a variety of reasons including the hands-on opportunities they provide students. The collaborations can also better prepare students for the workplace and together they can contribute to the local economy.

“We are delighted to continue our industry partnership with AVRA, which has embarked on a project to bring an autonomous medical robot to the marketplace,” said Dr. Qu, the principal investigator on the AVRA sponsored research project. He is also the chair of UCF’s Department of Electrical and Computer Engineering. “Our students have made technical contributions and have gained practical experience about the many ways robotics can be used to improve lives. We are happy to continue this research collaboration.”

About AVRA Medical Robotics
AVRA Medical Robotics, Inc., (OTCQB: AVMR) is transforming the practice of medicine by developing a fully autonomous surgical robotic system that “robotizes” a wide range of medical procedures currently being performed by human hands using surgical and non-surgical devices and instruments. AVRA is concentrating its research and development efforts to meet rising expectations of patients and practitioners alike for the precision, safety and speed offered by robotics and artificial intelligence as well as proprietary medical software architecture when combined with proven medical devices and surgical instruments. For more information visit the company’s website at www.avramedical.com.

University of Central Florida. Founded in 1963 with a commitment to expanding opportunity and demanding excellence, the University of Central Florida develops the talent needed to advance the prosperity and welfare of our society. With more than 68,000 students, UCF is one of the nation’s largest universities, offering more than 220 degree programs at its main campus in Orlando and more than a dozen other locations in Central Florida and online. For more information, visit ucf.edu.

Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or AVRA’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Barry Cohen 
AVRA Medical Robotics
Chairman and CEO

Adam Lowensteiner  
Lytham Partners, LLC